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Aims: Compare metabolic responses after mixed versus liquid meals of similar caloric/
nutritional content in healthy and type 2 diabetes (T2D) subjects.
Methods: Ten healthy men and 10 men with T2D received mixed and liquid meals after an
overnight fast. Classical (insulinogenic index; insulin/glucose areas under curves, AUCinsu-
lin/AUCglucose) and model-based (beta-cell glucose sensitivity; rate sensitivity; potentiation
factor ratio, PFR) beta-cell function estimates were calculated. Between-meal differences in
glucose, insulin, C-peptide, triglyceride (TG), beta-cell function and oral glucose insulin
sensitivity (OGIS) and between-meal correlations for beta-cell function and OGIS were
evaluated.
Results: Among healthy subjects, beta-cell function and OGIS were similar between meals.
C-peptide ( p = 0.03), insulin ( p = 0.002), AUCinsulin/AUCglucose ( p = 0.004) and insulin secre-
tion ( p = 0.04) were higher after the liquid meal. Among T2D subjects, glucose, insulin, C-
peptide, beta-cell function, and OGIS were similar. PFR was higher ( p = 0.004) and TG
increased more slowly ( p = 0.002) after the liquid meal. OGIS and beta-cell function were
correlated during both meals in both groups (r = 0.66–0.98), except incremental AUCinsulin/
AUCglucose, rate sensitivity, and, in healthy subjects, PFR.
Conclusions: Metabolic responses after mixed or liquid meals of similar content were highly
correlated in T2D and healthy subjects. In T2D, the liquid meal produced beta-cell function
estimates generally similar to the mixed meal.
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Identifying and characterizing individuals with altered beta-
cell function is important in understanding the natural history* Corresponding author. Tel.: +1 267 305 7490; fax: +1 215 616 2042.
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  Open access under the Elsevier OA licenseof diabetes, and potentially in identifying individuals in whom
interventions to prevent the onset of diabetes may be
important. Estimates of beta-cell function have mostly been
studied during non-physiological tests focusing on glucose-
stimulated insulin secretion such as hyperglycemic clamps orovicz@merck.com (K.G. Brodovicz).
.
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levels of insulin, glucose, C-peptide, incretin and triglyceride
have been shown to differ between mixed meal tolerance tests
(MTT) and OGTT [1–4], and with meal size and composition [5–7].
Nutrients other than glucose (e.g. whey protein, fat) have been
shown to stimulate insulinsecretion and incretin levels, enhance
postprandial beta-cell function, and slow gastric emptying [8–12].
MMTs are now preferred as the most physiologically relevant
challenge, approaching daily life situations.
Lately, different meal tests have been developed in several
studies [4,13,14]. The development and use of a single
standardized meal would be beneficial and facilitate compari-
son between studies. The most convenient option, especially
for epidemiological studies, would be a liquid meal test, which
would require no country-dependent ingredients, be easy to
prepare, and would not be impacted by individual variability in
chewing efficiency [15,16]. However, a liquid meal may not be
as representative of usual exposure to postprandial events as a
mixed meal. In the present study, metabolic responses
(glucose, insulin, C-peptide and triglyceride levels; classical
and model-based estimates of beta-cell function; model-based
estimate of insulin sensitivity) were compared during mixed
and liquid only meal tests of similar caloric and nutritional
content in both healthy men and men with type 2 diabetes.
2. Subjects, materials and methods
2.1. Study population
Ten healthy men [five non-obese (BMI < 30, median 24.7); five
obese (BMI > 30, median 35.8)] and 10 men with type 2
diabetes, participated. Type 2 diabetes subjects were on an
oral glucose lowering agent for at least 3 months (6 on
metformin, 1 on sulfonylurea, 3 on metformin–sulfonylurea).
Subjects on insulin, thiazolidinediones, and/or glucocorticoids
were excluded due to the effect these medications have on
insulin levels and insulin sensitivity [17]. Subjects with end-
stage renal disease or a hypersensitivity or dietary restriction
to the contents of the nutrition drink or meal were also
excluded. All participants signed an informed consent. The
study was approved by the ethical committee of the VU
University Medical Center.
2.2. Study procedure
Participants received a mixed and liquid only meal test after a
10-h overnight fast, separated by an average of 5 weeks (range 1–
12 weeks). The approximate total nutrient content in both
meals was 898 kcal (75 g carbohydrates, 50 g fat, of which 20.3 g
was saturated, and 36 g protein). The mixed meal consisted of
150 g Egg McMuffin (McDonald’s1), 50 g croissant, 10 g butter,
15 g jam, 200 ml full fat milk, 20 ml cream, and 11 ml lemon-
flavored concentrated syrup (Euroshopper). The liquid meal
contained 1 sachet Calshake vanilla (Fresenius Kabi Nederland
B.V.), 240 ml full-fat milk, 20 g sunflower oil, 5 g Fantomalt
powder (Nutricia, Zoetermeer, Netherlands) and 27 g Protifar
Plus (Nutricia). Meals were ingested within 10 min.
During both tests, blood samples were drawn fasting and at
10, 20, 30, 60, 90, 120, 150, 180 and 240 min following the start ofthe meal. Physical measurements (weight, height, waist and
hip circumference) and blood pressure were completed during
the first visit before the meal.
2.3. Beta-cell function estimates
2.3.1. Classical beta-cell function parameters
The insulinogenic index (an estimate of early insulin secre-
tion) was calculated by dividing the increment in insulin
during the first 30 postprandial minutes by the increment in
glucose over the same period [18]. Areas under the curve (AUC)
of insulin and glucose were calculated by the trapezium rule
during the 4-h postprandial period [19]. Overall glucose-
stimulated insulin secretion was calculated as AUCinsulin/
AUCglucose ratio and as the incremental AUC ratio (iAUCinsulin/
iAUCglucose).
2.3.2. Model-based beta-cell function parameters
Model-based beta-cell function parameters were calculated
using a mathematical model developed by Mari et al. [20,21].
Three main outcome parameters were calculated: beta-cell
glucose sensitivity, potentiation factor ratio, and rate sensitivi-
ty. The model describes the relationship between insulin
secretion and glucose concentration and expresses insulin
secretion (in pmol per min per square meter of body surface
area) as the sum of two components. The first component
represents the dependence of insulin secretion on absolute
glucose concentration at any time point during the test, and is
characterized by a dose–response function relating the two
variables. The characteristic parameter of the dose–response is
the mean slope within the observed glucose range, denoted as
beta-cell glucose sensitivity. The dose–response is modulated by a
potentiation factor, which accounts for the fact that during an
acute stimulation insulin secretion is higher on the descending
phase of hyperglycemia than at the same glucose concentration
on the ascending phase. As such, the potentiation factor
encompasses several potentiating mechanisms (prolonged
exposure to hyperglycemia, non-glucose substrates, gastroin-
testinal hormones, neural modulation). The potentiation factor
changes over time during the experiment, so it expresses the
relative potentiation (i.e. change of the relationship between
glucose concentration and amount of insulin secreted). To
quantify the potentiation factor excursion, the ratio between
the value the end of the test (220–240 min) and the initial value
(0–20 min) was calculated ( potentiation factor ratio).
The second insulin secretion component represents the
dependence of insulin secretion on the rate of change of
glucose concentration. This component is termed derivative
component, and is determined by a single parameter, denoted
as rate sensitivity. Rate sensitivity is related to early insulin
release [22]. The model parameters were estimated from
glucose and C-peptide concentration by regularized least-
squares, as previously described [19,20]. Fasting insulin
secretion rate and the integral of insulin secretion during
the whole test were also calculated.
2.4. Insulin sensitivity
The oral glucose insulin sensitivity (OGIS) index was estimated
from 3-h glucose and insulin values using methods described
Table 1 – Characteristics of the study population.
Healthy Type 2 diabetes
Age (years) 44.9 (24.1, 61.4) 57.1 (48.8, 63.1)*
Height (cm) 181.2 (174.7, 196.0) 178.0 (168.5, 187.4)
Weight (kg) 98.6 (67.0, 153.0) 89.6 (75.5, 100.4)
BMI (kg/m2) 28.2 (22.0, 39.8) 27.1 (24.9, 32.1)
Waist (cm) 102.6 (82.5, 137.3) 101.7 (87.9, 109.2)
Hip (cm) 104.8 (86.1, 122.3) 98.9 (95.1, 108.6)
Waist-hip ratio 1.0 (0.9, 1.1) 1.0 (0.9, 1.0)
Systolic blood
pressure (mmHg)
135.8 (109.0, 148.0) 141.9 (118.8, 160.3)
Diastolic blood
pressure (mmHg)
81.5 (64.5, 91.5) 82.8 (72.0, 94.8)
Total cholesterol
(mmol/l)
5.3 (3.5, 6.2) 4.3 (2.7, 6.8)
HDL cholesterol
(mmol/l)
1.1 (0.8, 1.6) 1.1 (0.8, 2.0)
LDL cholesterol
(mmol/l)
3.4 (1.8, 4.5) 2.3 (0.7, 4.6)
Triglyceride (mmol/l) 1.6 (0.6, 3.2) 1.6 (0.9, 3.8)
Values are median and range (minimum, maximum).
* Indicates statistical difference from the healthy subjects
( p = 0.01).
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highly correlated to OGTT-derived OGIS (r = 0.82) [3].
2.5. Postprandial lipid responses
Postprandial lipid responses were calculated as the AUC of the
triglyceride (TG) measurements at fasting, 60, 120, 180, and
240 min. The response relative to the baseline level was
determined by calculating the incremental area under the
curve (iAUC) of TG.
2.6. Laboratory analysis
Plasma glucose levels were determined with a glucose
hexokinase method (Gluco-quant, Roche Diagnostics, Man-
nheim, Germany), serum insulin and C-peptide with immu-
nometric assays (ACS Centaur, Bayer Diagnostics, Mijdrecht
The Netherlands), and TG, total cholesterol and HDL-choles-
terol by enzymatic colorimetric assays (Roche, Mannheim,
Germany). LDL-cholesterol was calculated according to the
Friedewald-formula.
2.7. Statistical analysis
Differences in the characteristics of healthy and type 2
diabetes subjects were determined with a Mann–Whitney–
Wilcoxon test. A Wilcoxon matched pairs signed rank sum test
was used to determine pairwise differences in AUCs of
glucose, insulin, C-peptide, TG and estimates of beta-cell
function between the meals. Correlations for beta-cell
function estimates between the meals were evaluated
separately for healthy and type 2 diabetes subjects using
Spearman correlation coefficients. p values <0.05 were
considered statistically significant. Statistical analysis was
performed using SAS version 9.1 (SAS Institute Inc., Cary, NC).
3. Results
Type 2 diabetes subjects were older than healthy subjects,
with a median age of 57 versus 45 years, respectively ( p = 0.01;
Table 1). The two groups were otherwise similar on physical
measurements, blood pressure, and baseline lipid levels.
Baseline fasting levels of glucose, insulin, C-peptide, and TG
were not significantly different between the meals, except for
glucose concentrations in healthy subjects ( p = 0.02) and C-
peptide in type 2 diabetes subjects ( p = 0.04; Figs. 1 and 2).
3.1. Healthy subjects
Among healthy subjects, the OGIS index and most beta-cell
function estimates were similar between the meals (Fig. 1,
Table 2). While the glucose response declined faster after the
mixed meal, the difference in AUC between the meals was not
statistically significant ( p = 0.06; Fig. 1). The TG response
increased faster and higher after the liquid meal but was not
statistically significant ( p = 0.09). The insulin and C-peptide
responses were statistically higher and slower to decline after
the liquid meal (AUC and iAUC insulin: p = 0.002, C-peptide:
p = 0.03). Glucose-stimulated insulin secretion, defined as theAUCinsulin/AUCglucose ratio, ( p = 0.004) and the integral of
insulin secretion ( p = 0.04) were both higher after the liquid
meal (Table 2). The insulinogenic index, AUCinsulin/AUCglucose
ratio, beta-cell glucose sensitivity, the integral of insulin
secretion, and the OGIS index following each meal were
positively correlated (r = 0.66–0.93; Table 2).
3.2. Type 2 diabetes subjects
Among type 2 diabetes subjects, glucose, insulin C-peptide,
the OGIS index, and most beta-cell function estimates were
similar after each meal (Fig. 2, Table 2). In contrast to healthy
subjects, the TG response increased more slowly after the
liquid meal (iAUC p = 0.002). The potentiation factor ratio was
higher after the liquid meal ( p = 0.004). The insulinogenic
index, AUCinsulin/AUCglucose ratio, beta-cell glucose sensitivity,
potentiation factor ratio, the integral of insulin secretion, and
the OGIS index following each meal were positively correlated
(r = 0.77–0.98).
3.3. Healthy versus type 2 diabetes subjects
As expected, glucose values were higher in type 2 diabetes
subjects ( p < 0.01) and the glucose responses differed, with
peak glucose level occurring later in the type 2 diabetes
subjects ( p < 0.05). The C-peptide and TG responses after the
mixed meal also differed between healthy and type 2 diabetes
subjects, with peak C-peptide levels occurring later in the type
2 diabetes subjects (mixed meal iAUC p = 0.04) and slightly
lower TG levels in type 2 diabetes subjects (mixed meal iAUC
p = 0.01).
The insulinogenic index and beta-cell glucose sensitivity
differed between healthy and type 2 diabetes subjects in
response to both the liquid (insulinogenic index p = 0.03; beta-
cell glucose sensitivity p = 0.01) and mixed meals (insulino-
genic index p = 0.04; beta-cell glucose sensitivity p = 0.01). The
iAUC ratio ( p = 0.02) and the potentiation factor ratio ( p = 0.01)
Fig. 1 – Glucose (a), insulin (b), C-peptide (c), and triglyceride (d) responses (mean W SE) to a standardized mixed (closed
circles) or liquid meal (open circles) in healthy subjects. Footnotes: BL, baseline; AUC, area under the curve; iAUC,
incremental area under the curve.
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only reached significance in response to the liquid meal.
However, after adjusting for age, these differences were no
longer significant. The OGIS index also differed between the
groups, but only after the mixed meal ( p = 0.003). Most
estimates of beta-cell function after each meal were highly
correlated in both groups. Among type 2 diabetes subjects,
potentiation factor ratio was highly correlated (r = 0.78),
whereas no correlation was observed among healthy subjects
(r = 0.43).
4. Discussion
This study aimed to answer the question whether a liquid meal
challenge elicits postprandial metabolic responses similar to a
mixed meal. The results show both meal tests rank individuals
in a similar way. Furthermore, in type 2 diabetes subjects, the
postprandial metabolic responses were largely similar. Com-
parable glucose, insulin, and C-peptide trends were observedand estimates of beta-cell function were not statistically
different between the meals, but TG levels increased more
slowly after the liquid meal. In healthy subjects however, the
liquid meal did elicit higher glucose (borderline significance,
p = 0.06), C-peptide, and insulin responses.
Several studies suggest MTT to be more reflective of real
world postprandial metabolic responses than OGTT. Gastric
emptying is more rapid after OGTT than after a solid meal,
leading to a rapid flow of glucose into the duodenum and the
portal venous circulation [24–26]. The protein and fat of a
mixed meal delay gastrointestinal glucose absorption, leading
to shallower patterns of postprandial glucose excursion [6,10].
Lastly, postprandial responses of gastrointestinal incretin
hormones, such as gastric inhibitory peptide (GIP), differ
between MTT and OGTT, with GIP levels higher after a mixed
meal [4]. While mixed meal tests are generally accepted as a
better test of real world postprandial response, comparisons
between studies of metabolic responses to meal challenges
are hampered due to differences in meal size and content
[5–12].
Fig. 2 – Glucose (a), insulin (b), C-peptide (c), and triglyceride (d) responses (mean W SE) to a standardized mixed (closed
circles) or liquid meal (open circles) in type 2 diabetes subjects. Footnotes: BL, baseline; AUC, area under the curve; iAUC,
incremental area under the curve.
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implement than a mixed meal. A standardized liquid meal test
would facilitate comparisons across studies and countries and
eliminate the intra- and inter-subject variability observed in
chewing solid meals [15,16]. From this perspective, a liquid meal
test is preferable over a mixed meal test. However, data
evaluating meal types (mixed versus liquid only) with similar
nutrient value on metabolic response had not previously been
reported.
This study also highlights the dynamic characteristics of the
insulin and glucose responses. The model-based estimates of
beta-cell function capture this dynamic. In type 2 diabetes
subjects, the potentiation factor ratio was higher after the liquid
meal (Table 2). This indicates that for the same glucose levels
insulin secretion is somewhat higher at the end of the test
compared to the beginning. This may be related to the relative
hyperglycemia of the liquid meal, as it has been shown that
hyperglycemia produces such an amplification [27]. Potentiation
may also be related to factors other than glucose alone, including
incretins, which has to be futher investigated. Total insulin and
glucose AUCs remained similar after either meal (Fig. 2).Limitations of the present study should be considered. This
study was limited to a small number of Caucasian healthy and
well-controlled type 2 diabetes male subjects from The
Netherlands; therefore, caution should be used in generalizing
these results to other populations. However, these results are
generally consistent with other studies reporting differing
metabolic responses by meal size and composition. The
importance of gut-derived hormones for postprandial metab-
olism is now appreciated. Incretin and glucagon responses, as
well as gastric emptying rates, may also be influenced by the
type of meal and may explain some of the differences
observed between the meal tests; however, these data are
not available from this study. In healthy subjects, fasting
glucose was lower on the day of the meal test. This might be
attributable to the encephalic, anticipatory effect of a meal
[28,29]. These baseline glucose differences in healthy subjects
may be at least partially responsible for the subsequent
between meal differences observed in this group; however, the
insulinogenic index was not statistically different between the
meals. While caloric load and content of total carbohydrates,
fat, and protein were similar between the mixed and liquid
Table 2 – Estimates of beta-cell function between mixed and liquid meals in healthy and type 2 diabetes subjects.
Estimates of beta-cell function Mixed meal Liquid meal Wilcoxon
p value
Spearman correlation
coefficient ( p value)
Healthy subjects
Insulinogenic index (pmol/mmol) 146.6 (73.9, 464.7) 230.1 (79.0, 562.3) 0.16 0.77 (0.01)
AUCinsulin/AUCglucose ratio (pmol/mmol) 36.8 (21.6, 61.5) 43.0 (28.0, 75.8) 0.004 0.88 (0.001)
iAUCinsulin/iAUCglucose (pmol/mmol) 239.6 (106.9, 628.3) 326.2 (119.0, 4618.1) 0.08 0.39 (0.26)
Beta-cell glucose sensitivity
(pmol/min/m2/mM)
150.6 (72.5, 315.7) 140.8 (34.6, 348.7) 0.43 0.90 (0.0003)
Rate sensitivity (pmol/m2/mM) 859.4 (1.4E14, 2915.5) 1112.3 (159.6, 3331.3) 0.32 0.19 (0.60)
Potentiation factor ratio (fold) 1.2 (0.8, 2.2) 1.3 (0.8, 1.7) 0.77 0.43 (0.21)
3-h OGIS index 440.3 (315.6, 499.1) 399.3 (301.1, 511.9) 0.16 0.72 (0.02)
Integral of insulin secretion 50.0 (32.6, 65.4) 52.9 (41.6, 86.1) 0.04 0.66 (0.04)
Type 2 diabetes subjects
Insulinogenic index (pmol/mmol) 75.5 (14.8, 274.6) 71.4 (19.8, 288.4) 0.77 0.81 (0.005)
AUCinsulin/AUCglucose ratio (pmol/mmol) 33.5 (14.1, 144.8) 37.6 (13.1, 132.7) 0.92 0.98 (<0.0001)
iAUCinsulin/iAUCglucose (pmol/mmol) 289.7 (46.8, 710.4) 131.3 (1197.6, 390.7) 0.05 0.07 (0.85)
Beta-cell glucose sensitivity (pmol/min/m2/mM) 41.8 (14.8, 142.3) 40.1 (6.8, 104.7) 0.06 0.77 (0.01)
Rate sensitivity (pmol/m2/mM) 401.4 (1.1E14, 2165.6) 884.5 (51.6, 3689.3) 0.13 0.10 (0.78)
Potentiation factor ratio (fold) 1.5 (0.9, 2.1) 1.8 (1.2, 3.9) 0.004 0.78 (0.008)
3-h OGIS index 298.8 (196.4, 387.1) 319.2 (227.2, 435.4) 0.08 0.81 (0.005)
Integral of insulin secretion 64.9 (41.1, 130.5) 62.8 (45.6, 131.3) 0.92 0.85 (0.002)
Values are median and range (minimum, maximum).
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proteins) and proportion of simple versus complex carbohy-
drates and saturated versus unsaturated fat remain. While
these difference in the meals can impact rates of absorption
and gastric emptying, both tests were able to discriminate
abnormal metabolism. Further work on standardization of the
meal test to insure its validity under different protocols and in
different research settings is needed. A considerable strength
of the present study is the comparison of standardized mixed
and liquid meals of similar caloric and macronutrient content
within the same study.
In conclusion, in type 2 diabetes subjects, postprandial
metabolic responses were largely similar and well-correlated
after a mixed or liquid meal test of similar caloric and
nutritional content. In healthy subjects, the comparability of
the liquid meal to the mixed meal was less clear. Further work
is needed to clarify this comparison. While there are
advantages and disadvantages to both meal tests, in studies
of type 2 diabetes subjects, the standardized liquid meal test
may be a good alternative to a mixed meal test for cross-
country standardization and produces beta-cell function
estimates comparable to mixed meal tests.
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